AXT INC
For the period ended Dec 31, 2025. Filed Mar 17, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 17, 2026
AXTI$39.31-8.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
(In thousands)
| Common Stock | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated | |||||||||||||||||||||||
| Preferred · Additional · Other · AXT, Inc. · Total | |||||||||||||||||||||||
| Stock · Paid-In · Accumulated · Comprehensive · Stockholders’ · Noncontrolling · Stockholders’ | |||||||||||||||||||||||
| Shares · Amount · Shares · Amount · Capital · Deficit · Income (Loss) · Equity · Interests · Equity | |||||||||||||||||||||||
| Balance as of January 1, 2023 | 883 | $3,532 | 43,554 | 44 | 235,308 | (14,159) | (3,118) | 221,607 | 23,293 | 244,900 | |||||||||||||
| Common stock options exercised | 4 | 10 | 10 | 10 | |||||||||||||||||||
| Investment in subsidiary with noncontrolling interest | (153) | (153) | 861 | 708 | |||||||||||||||||||
| Investment in subsidiary with redeemable noncontrolling interest | (155) | (155) | (155) | ||||||||||||||||||||
| Restricted stock awards canceled | (23) | — | — | ||||||||||||||||||||
| Stock-based compensation | 2,779 | 2,779 | 2,779 | ||||||||||||||||||||
| Issuance of common stock in the form of restricted stock | 704 | — | — | ||||||||||||||||||||
| Tongmei stock-based compensation | 761 | 761 | 761 | ||||||||||||||||||||
| Noncontrolling interest portion of Tongmei stock-based compensation | (98) | (98) | 55 | (43) | |||||||||||||||||||
| Net loss | (17,881) | (17,881) | (391) | (18,272) | |||||||||||||||||||
| Other comprehensive loss | (2,881) | (2,881) | (324) | (3,205) | |||||||||||||||||||
| Balance as of December 31, 2023 | 883 | 3,532 | 44,239 | 44 | 238,452 | (32,040) | (5,999) | 203,989 | 23,494 | 227,483 | |||||||||||||
| Common stock options exercised | 12 | 1 | 27 | 28 | 28 | ||||||||||||||||||
| Restricted stock awards canceled | (6) | — | — | ||||||||||||||||||||
| Stock-based compensation | 2,647 | 2,647 | 2,647 | ||||||||||||||||||||
| Issuance of common stock in the form of restricted stock | 1,113 | — | — | ||||||||||||||||||||
| Tongmei stock-based compensation | 450 | 450 | 450 | ||||||||||||||||||||
| Noncontrolling interest portion of Tongmei stock-based compensation | (62) | (62) | 31 | (31) | |||||||||||||||||||
| Net loss | (11,624) | (11,624) | 342 | (11,282) | |||||||||||||||||||
| Other comprehensive loss | (2,658) | (2,658) | (306) | (2,964) | |||||||||||||||||||
| Balance as of December 31, 2024 | 883 | 3,532 | 45,358 | 45 | 241,514 | (43,664) | (8,657) | 192,770 | 23,561 | 216,331 | |||||||||||||
| Common stock options exercised | 339 | 1,605 | 1,605 | 1,605 | |||||||||||||||||||
| Restricted stock awards canceled | (51) | — | — | ||||||||||||||||||||
| Stock-based compensation | 3,109 | 3,109 | 3,109 | ||||||||||||||||||||
| Issuance of common stock in the form of restricted stock | 1,528 | 2 | 2 | 2 | |||||||||||||||||||
| Issuance of common stock, net of stock issuance costs of $6,450 | 8,163 | 8 | 93,542 | 93,550 | 93,550 | ||||||||||||||||||
| Tongmei stock-based compensation | 183 | 183 | 183 | ||||||||||||||||||||
| Noncontrolling interest portion of Tongmei stock-based compensation | (31) | (31) | 13 | (18) | |||||||||||||||||||
| Net loss | (21,260) | (21,260) | (709) | (21,969) | |||||||||||||||||||
| Other comprehensive income | 3,362 | 3,362 | 420 | 3,782 | |||||||||||||||||||
| Balance as of December 31, 2025 | 883 | $3,532 | 55,337 | $55 | $339,922 | $(64,924) | $(5,295) | $273,290 | $23,285 | $296,575 | |||||||||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.